Teramoto S., Tomita T., Matsui H., Ohga E., Matsuse T., Ouchi Y
Modern technology offers powerful tools to help you do this, including continuous glucose monitors (CGMs) and smart scales
But about half of people with obesity on this class of medications, called glucagon-like peptide agonists or GLP-1s, stop taking it within a year
Because these medications address the root causes of metabolic dysfunction, several key markers typically trend in a healthier direction
BMC Ophthalmol 20:73
For biosynthesis, it seems the only strategy to prolong the half-life is a ligand fused with a terminal albumin or Fc domain, whose critical points are length and location